{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:32:47Z","timestamp":1792701167834,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100006390","name":"University of Lausanne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006390","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"DOI":"10.1186\/s42358-025-00457-4","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T10:38:38Z","timestamp":1749724718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Fibromyalgia with concomitant immune-mediated rheumatic diseases: an evaluation of clinical characteristics, diagnostic criteria and multimodal treatment outcomes"],"prefix":"10.1186","volume":"65","author":[{"given":"Johanna","family":"Mettler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Ming-Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3276-9581","authenticated-orcid":false,"given":"Thomas","family":"H\u00fcgle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"457_CR1","doi-asserted-by":"publisher","unstructured":"Sarzi-Puttini P, Giorgi V, Marotto D, Atzeni F. Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment. Nat Rev Rheumatol. 2020;16(11):645\u201360. https:\/\/doi.org\/10.1038\/s41584-020-00506-w.","DOI":"10.1038\/s41584-020-00506-w"},{"key":"457_CR2","doi-asserted-by":"publisher","unstructured":"Duffield SJ, Miller N, Zhao S, Goodson NJ. Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2018;57(8):1453\u20131460. https:\/\/doi.org\/10.1093\/rheumatology\/key112","DOI":"10.1093\/rheumatology\/key112"},{"key":"457_CR3","doi-asserted-by":"publisher","unstructured":"Salaffi F, De Angelis R, Carotti M, Gutierrez M, Sarzi-Puttini P, Atzeni F. Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity. Rheumatol Int. 2014;34(8):1103\u201310. https:\/\/doi.org\/10.1007\/s00296-014-2955-9","DOI":"10.1007\/s00296-014-2955-9"},{"key":"457_CR4","doi-asserted-by":"publisher","unstructured":"Haliloglu S, Carlioglu A, Akdeniz D, Karaaslan Y, Kosar A. Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity. Rheumatol Int. 2014;34(9):1275-80. https:\/\/doi.org\/10.1007\/s00296-014-2972-8","DOI":"10.1007\/s00296-014-2972-8"},{"key":"457_CR5","doi-asserted-by":"publisher","unstructured":"Hench PK. Secondary fibrositis. Am J Med. 1986;81(3a):60\u2013\u20092. https:\/\/doi.org\/10.1016\/0002-9343(86)90877-6","DOI":"10.1016\/0002-9343(86)90877-6"},{"key":"457_CR6","doi-asserted-by":"publisher","unstructured":"Wolfe F, et al. The American college of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010;62(5):600\u201310. https:\/\/doi.org\/10.1002\/acr.20140.","DOI":"10.1002\/acr.20140"},{"key":"457_CR7","doi-asserted-by":"publisher","unstructured":"Zhao SS, Duffield SJ, Goodson NJ. The prevalence and impact of comorbid fibromyalgia in inflammatory arthritis. Best Pract Res Clin Rheumatol. 2019;33(3):101423. https:\/\/doi.org\/10.1016\/j.berh.2019.06.005.","DOI":"10.1016\/j.berh.2019.06.005"},{"key":"457_CR8","doi-asserted-by":"publisher","unstructured":"Salaffi F, Farah S, Bianchi B, Di Carlo M. Central sensitization in psoriatic arthritis: relationship with composite measures of disease activity, functional disability, and health-related quality of life. J Rheumatol. 2024;51(2):144\u2013149. https:\/\/doi.org\/10.3899\/jrheum.2023-0177","DOI":"10.3899\/jrheum.2023-0177"},{"key":"457_CR9","doi-asserted-by":"publisher","unstructured":"Jiao J, Davis Iii JM, Cha SS, Luedtke CA, Vincent A, Oh TH. Association of rheumatic diseases with symptom severity, quality of life, and treatment outcome in patients with fibromyalgia. Scand J Rheumatol. Jan 2016;45(1):49\u201356. https:\/\/doi.org\/10.3109\/03009742.2015.1052553.","DOI":"10.3109\/03009742.2015.1052553"},{"key":"457_CR10","doi-asserted-by":"publisher","unstructured":"Bello N, Etcheto A, B\u00e9al C, Dougados M, Molt\u00f3 A. Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis. Arthritis Res Ther. 9 2016;18:42. https:\/\/doi.org\/10.1186\/s13075-016-0943-z.","DOI":"10.1186\/s13075-016-0943-z"},{"key":"457_CR11","doi-asserted-by":"publisher","unstructured":"Wach J, Letroublon MC, Coury F, Tebib JG. Fibromyalgia in spondyloarthritis: effect on disease activity assessment in clinical practice. J Rheumatol. 2016;43(11):2056\u201363. https:\/\/doi.org\/10.3899\/jrheum.160104","DOI":"10.3899\/jrheum.160104"},{"key":"457_CR12","doi-asserted-by":"publisher","unstructured":"Gist AC, Guymer EK, Eades LE, Leech M, Littlejohn GO. Fibromyalgia remains a significant burden in rheumatoid arthritis patients in Australia. Int J Rheum Dis. 2018;21(3):639\u2013646. https:\/\/doi.org\/10.1111\/1756-185x.13055","DOI":"10.1111\/1756-185x.13055"},{"key":"457_CR13","doi-asserted-by":"publisher","unstructured":"Coury F, et al. Rheumatoid arthritis and fibromyalgia: a frequent unrelated association complicating disease management. J Rheumatol. 2009;36(1):58\u201362. https:\/\/doi.org\/10.3899\/jrheum.080366.","DOI":"10.3899\/jrheum.080366"},{"key":"457_CR14","doi-asserted-by":"publisher","unstructured":"Perrot S, Bouhassira D, Fermanian J. Development and validation of the Fibromyalgia Rapid Screening Tool (FiRST). Pain. 2010;150(2):250\u2013256. https:\/\/doi.org\/10.1016\/j.pain.2010.03.034","DOI":"10.1016\/j.pain.2010.03.034"},{"key":"457_CR15","doi-asserted-by":"publisher","unstructured":"Fan A, et al. Frequency of concomitant fibromyalgia in rheumatic diseases: Monocentric study of 691 patients. Semin Arthritis Rheum. 2017;47(1):129\u2013132. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.01.005","DOI":"10.1016\/j.semarthrit.2017.01.005"},{"key":"457_CR16","doi-asserted-by":"publisher","unstructured":"Rasker JJ, Wolfe F, Michaud K, Ten Klooster PM. Looking at Fibromyalgia differently - the meaning and consequences of fibromyalgia as a dimensional disorder. Semin Arthritis Rheum. 2023;63:152262. https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152262","DOI":"10.1016\/j.semarthrit.2023.152262"},{"key":"457_CR17","unstructured":"Di Franco M, et al. Misdiagnosis in fibromyalgia: a multicentre study. Clin Exp Rheumatol. 2011;29(6 Suppl 69):S104-8."},{"key":"457_CR18","doi-asserted-by":"publisher","unstructured":"Walsh JA, Magrey M. Clinical manifestations and diagnosis of axial spondyloarthritis. J Clin Rheumatol. 2021;27(8):e547\u2013e560. https:\/\/doi.org\/10.1097\/rhu.0000000000001575","DOI":"10.1097\/rhu.0000000000001575"},{"key":"457_CR19","doi-asserted-by":"publisher","unstructured":"Atzeni F, et al. Chronic widespread pain in spondyloarthritis. Reumatismo. 2014;66(1):28\u201332. https:\/\/doi.org\/10.4081\/reumatismo.2014.761","DOI":"10.4081\/reumatismo.2014.761"},{"key":"457_CR20","doi-asserted-by":"publisher","unstructured":"Neuenschwander R, et al. Differences between men and women with nonradiographic axial spondyloarthritis: clinical characteristics and treatment effectiveness in a real-life prospective cohort. Arthritis Res Ther. 2020;22(1):233. https:\/\/doi.org\/10.1186\/s13075-020-02337-2.","DOI":"10.1186\/s13075-020-02337-2"},{"key":"457_CR21","doi-asserted-by":"publisher","unstructured":"Jones GT, Mallawaarachchi B, Shim J, Lock J, Macfarlane GJ. The prevalence of fibromyalgia in axial spondyloarthritis. Rheumatol Int. 2020;40(10):1581\u20131591. https:\/\/doi.org\/10.1007\/s00296-020-04621-5","DOI":"10.1007\/s00296-020-04621-5"},{"key":"457_CR22","doi-asserted-by":"publisher","unstructured":"Cengiz G, \u015ea\u015f S, Kaplan H, \u00d6zsoy S, \u00c7al\u0131\u015f M. The influence of alexithymia on disease activity and quality of life in patients with axial spondyloarthritis: A cross-sectional study. Int J Rheum Dis. 2023;26(6):1091\u2013102. https:\/\/doi.org\/10.1111\/1756-185x.14704.","DOI":"10.1111\/1756-185x.14704"},{"key":"457_CR23","doi-asserted-by":"publisher","unstructured":"L\u00f8ge-Hagen JS, S\u00e6le A, Juhl C, Bech P, Stenager E, Mellentin AI. Prevalence of depressive disorder among patients with fibromyalgia: systematic review and meta-analysis. J Affect Disord. 2019;245:1098\u2013105. https:\/\/doi.org\/10.1016\/j.jad.2018.12.001","DOI":"10.1016\/j.jad.2018.12.001"},{"key":"457_CR24","doi-asserted-by":"publisher","unstructured":"Serrat M, et al. Effectiveness of a multicomponent treatment based on pain neuroscience education, therapeutic exercise, cognitive behavioral therapy, and mindfulness in patients with fibromyalgia (FIBROWALK study): A randomized controlled trial. Phys Ther. 2021;101(12). https:\/\/doi.org\/10.1093\/ptj\/pzab200","DOI":"10.1093\/ptj\/pzab200"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-025-00457-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-025-00457-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-025-00457-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T09:42:48Z","timestamp":1763545368000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-025-00457-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["457"],"URL":"https:\/\/doi.org\/10.1186\/s42358-025-00457-4","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]},"assertion":[{"value":"16 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}